Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

REVIVE-ing a Weak Heart - Details Matter.

The New England journal of medicine·2022

Same author

One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape.

Cardiovascular revascularization medicine : including molecular interventions·2022

Same author

Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2022

Same author

Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review.

JAMA cardiology·2022

Same author

Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.

JACC. Cardiovascular interventions·2022

Same author

Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.

JAMA cardiology·2022

Search research articles

Related Experiment Video

Updated: May 27, 2026

Mouse Models for Graft Arteriosclerosis

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Cardiac allograft vasculopathy.

Michael S Lee¹, Will Finch, Giora Weisz

¹University of California, Los Angeles Medical Center, Los Angeles, CA, USA.

Reviews in Cardiovascular Medicine

|November 15, 2011

Summary

Cardiac allograft vasculopathy (CAV) significantly impacts heart transplant recipients. Management involves immunosuppression, risk factor modification, and revascularization, but repeat transplantation remains the only definitive treatment.

Area of Science:

Cardiology
Transplantation Immunology

Background:

Cardiac allograft vasculopathy (CAV) is a primary cause of death and illness after heart transplants.
It involves immune-mediated endothelial damage, leading to vascular smooth muscle cell proliferation and narrowed arteries.

Purpose of the Study:

To review the risk factors, diagnosis, management, and treatment of CAV.
To highlight the limitations of current interventions and the need for further research.

Main Methods:

Review of existing literature on CAV.
Discussion of diagnostic tools like coronary angiography and intravascular ultrasound.
Analysis of management strategies including immunosuppression, risk factor modification, and revascularization.

Main Results:

More Related Videos

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Related Experiment Videos

Last Updated: May 27, 2026

Mouse Models for Graft Arteriosclerosis

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

CAV is driven by immunologic damage and endothelial infiltration.
Percutaneous coronary intervention (PCI) has high immediate success but high in-stent restenosis rates, though drug-eluting stents offer improvement.
Repeat transplantation is the only definitive treatment for CAV.

Conclusions:

Optimal immunosuppressive and risk factor-modifying agents require further study.
Randomized trials are essential to define the best revascularization strategies for CAV patients.